178 - Tetanus
نویسنده
چکیده
of the clinical presentation of the disease. The diagnosis can be suspected but not confirmed in the emergency depart ment (ED). In addition to recognizing the clinical presentation of tetanus, EPs play a vital role in the prevention of the disease. Primary pediatric vaccination and regular decennial booster vaccination are the mainstays of disease prevention and sever ity modulation. Herd immunity does not occur with tetanus. Therefore, only people who receive the vaccination benefit from immunization. In the United States, the prevalence of tetanus immunity decreases by age, after 40 years of age. At 40 years of age, 80% of the population is immune to tetanus. By the age of 80 years, only 30% of the population remains immune. This decrease is most striking in women and Mexican Americans. Only 36% of persons age 65 years old or older report receiving tetanus vaccination in the past 10 years. Most cases of tetanus and fatalities resulting from tetanus are in patients who either have never been vaccinated or have not had a booster in the past 10 years. EPs have the opportunity to provide booster vaccination at times of minor to severe injury and skin infection. In light of pertussis epidemics, • Puncture wounds pose the highest risk for tetanus. Tetanus also occurs following clean, minor wounds, abscesses, and cellulitis. • Keep current the tetanus immunization status of patients with any injury, even minor, clean wounds. • Give tetanus immune globulin to patients with wounds, other than clean, simple wounds, who have never completed a primary tetanus immunization series. • Tetanus is a clinical diagnosis. Begin treatment when the diagnosis is suspected in any patient with unexplained rigidity. • Tetanus treatment consists of tetanus immune globulin, antibiotics, and local wound care. KEY POINTS
منابع مشابه
Tetanus and Diphtheria Seroprevalence in Patients Infected With Human Immunodeficiency Virus
Background and Objectives: HIV infected patients are at risk for vaccine-preventable infections such as tetanus and diphtheria (Td). In these patients, these antibodies tend to decline faster. Due to the limited data, this study assessed the seroprevalence of tetanus and diphtheria antibodies in HIV infected patients in Tehran, Iran. Materials and Methods: This case-control study was carried o...
متن کاملThe use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study
BACKGROUND The Dutch National Immunisation Programme includes six tetanus toxoid (TT) vaccinations and reaches a high rate of vaccination coverage. In the Netherlands, several guidelines related to tetanus post-exposure prophylaxis (T-PEP) are in place. In 2003, the Dutch Health Council (HC) reviewed the use of T-PEP. The aim of this study is to evaluate whether the HC recommendations have been...
متن کاملOral Immunization against Diphtheria and Tetanus Infections by Fluid Dphtheria and Tetanus Toxoids
متن کامل
Humoral immune response to Diphtheria and Tetanus toxoids by intranasal administration
The immunogenicity of ten different formulations of intranasal diphtheria and tetanus vaccines which containing different absorption enhancers, adjuvants and other excipients were determined in guinea pigs by the serum neutralization (SN) method. From these ten formulations, it was selected four formulations which gave significant immunogenicity in guinea pigs. In order to design the "final f...
متن کاملNeonatal Tetanus in Mashhad (North East of Iran) over a 17 Year period
Introduction: Neonatal tetanus is a highly fatal disease that can be prevented by immunization and improvement in obstetric practices. The aim of the present study was to assess the characteristics of cases of neonatal tetanus in two large tertiary hospitals (Ghaem and Imam Reza hospitals) of Mashhad -North East of Iran between 1984- 2001. Methods: all cases whose epidemiological and clinical c...
متن کامل